Traws Pharma, Inc. — Director's Dealing 2018

Feb 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2018-02-23

Reporting Person: Kumar Ramesh (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-23	Stock Option (right to purchase)	$1.09	A	73220	Acquired	2028-02-23	Common Stock (73220)	Direct

Footnotes

F1: This option grant was made in lieu of cash payment for a portion of Dr. Kumar's year-end bonus. The options vest immediately.